Sell on Novo Nordisk A/S: slowing growth, downgraded 2025 guidance, rising GLP-1 competition, pricing/patent risks, limited ...

One Fiserv reset, Clover growth, and a single-digit P/E offering upside despite 2026 headwinds—read the analysis now.

Enterprise Products Partners (EPD) looks attractive amid oil volatility, with strong cash flow, dividend growth, and DDM ...

Ron Baron’s BAMCO 13F: top holdings (Tesla, MSCI), major stake changes, and growth strategy insights. Read here for more ...

Michigan Consumer Sentiment Index dropped 1.1 points (-1.9%) to 55.5 this month, coming in above the forecasted 55.0.

Q4 earnings and ROE dipped, asset quality needs monitoring, and valuation looks rich. Read here for a detailed analysis.

S&P 500 correction, with the market already pricing in some conflict risk. Prolonged conflict may sustain oil above ...

Real GDP rose at just a 0.7% annual rate, falling well short of the 1.4% forecast and marking a steep drop-off from the 4.4% ...

AI bubble or normal reset? Learn why today’s AI cycle looks grounded in fundamentals, what volatility to expect, and how to ...

Cohen & Steers Quality Income Realty Fund has dipped 6%, raising its yield to 8.7% & presenting a potential buying ...

Zoom stock is still far below Cathie Wood’s $1,500 ARK forecast for 2026. See what happened since 2022. Learn more here.

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...